A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinomaPOPA, Irina E; STEWART, Kathleen; SMITH, Frederick P et al.Cancer. 2002, Vol 95, Num 8, pp 1714-1719, issn 0008-543X, 6 p.Article

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancerMILLER, Vincent A; KRIS, Mark G; TYSON, Leslie et al.Journal of clinical oncology. 2004, Vol 22, Num 6, pp 1103-1109, issn 0732-183X, 7 p.Article

A Phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancersBHARGAVA, Pankaj; MARSHALL, John L; DAHUT, William et al.Clinical cancer research. 2001, Vol 7, Num 12, pp 3912-3919, issn 1078-0432Article

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon19 and exon 21 mutations treated with gefitinib or erlotinibRIELY, Gregory J; PAO, William; PHAM, Duykhanh et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 839-844, issn 1078-0432, 6 p., 1Article

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein : A phase II clinical trialKRUG, Lee M; CRAPANZANO, John P; HEELAN, Robert T et al.Cancer. 2005, Vol 103, Num 10, pp 2128-2131, issn 0008-543X, 4 p.Article

Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patientsCASSILETH, Barrie R; RIZVI, Naiyer; DENG, Gary et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 67-71, issn 0344-5704, 5 p.Article

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancersPECORA, Andrew L; RIZVI, Naiyer; ROBERTS, M. Scot et al.Journal of clinical oncology. 2002, Vol 20, Num 9, pp 2251-2266, issn 0732-183XArticle

Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid TumorsLORUSSO, Patricia; JÄNNE, Pasi A; ANG, Agnes et al.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 3078-3087, issn 1078-0432, 10 p.Article

Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase FusionsSUEHARA, Yoshiyuki; ARCILA, Maria; KRIS, Mark G et al.Clinical cancer research (Print). 2012, Vol 18, Num 24, pp 6599-6608, issn 1078-0432, 10 p.Article

Lung cancer : Computerized quantification of tumor responseinitial resultsBINSHENG ZHAO; SCHWARTZ, Lawrence H; MOSKOWITZ, Chaya S et al.Radiology. 2006, Vol 241, Num 3, pp 892-898, issn 0033-8419, 7 p.Article

A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapyRIELY, Gregory J; GADGEEL, Shirish; ROTHMAN, Ivan et al.Lung cancer. 2007, Vol 55, Num 2, pp 181-185, issn 0169-5002, 5 p.Article

A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancerMILTON, Daniel T; AZZOLI, Christopher G; MILLER, Vincent A et al.Cancer. 2006, Vol 107, Num 5, pp 1034-1041, issn 0008-543X, 8 p.Article

Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non-Small-Cell Lung CancerRIZVI, Naiyer A; RIELY, Gregory J; KRIS, Mark G et al.Journal of clinical oncology. 2008, Vol 26, Num 4, pp 639-643, issn 0732-183X, 5 p.Article

Core Needle Lung Biopsy Specimens: Adequacy for EGFR and KRAS Mutational AnalysisSOLOMON, Stephen B; ZAKOWSKI, Maureen F; PAO, William et al.American journal of roentgenology (1976). 2010, Vol 194, Num 1, pp 266-269, issn 0361-803X, 4 p.Article

Vandetanib Versus Gefitinib in Patients With Advanced Non―Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II StudyNATALE, Ronald B; BODKIN, David; RANSON, Malcolm et al.Journal of clinical oncology. 2009, Vol 27, Num 15, pp 2523-2529, issn 0732-183X, 7 p.Article

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancerMILTON, Daniel T; RIELY, Gregory J; MILLER, Vincent A et al.Cancer. 2007, Vol 110, Num 3, pp 599-605, issn 0008-543X, 7 p.Article

A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumorsFURY, Matthew G; KRUG, Lee M; AZZOLI, Christopher G et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 5, pp 671-677, issn 0344-5704, 7 p.Article

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancerBHARGAVA, Pankaj; MARSHALL, John L; RIZVI, Naiyer A et al.Cancer chemotherapy and pharmacology. 2001, Vol 48, Num 2, pp 95-103, issn 0344-5704Article

Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomasLAMPEN-SACHAR, Katharine; BINSHENG ZHAO; JUNTING ZHENG et al.Lung cancer. 2012, Vol 75, Num 3, pp 332-335, issn 0169-5002, 4 p.Article

Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to ErlotinibJANJIGIAN, Yelena Y; AZZOLI, Christopher G; RIELY, Gregory J et al.Clinical cancer research (Print). 2011, Vol 17, Num 8, pp 2521-2527, issn 1078-0432, 7 p.Article

A Pilot Study of Volume Measurement as a Method of Tumor Response Evaluation to Aid Biomarker DevelopmentBINSHENG ZHAO; OXNARD, Geoffrey R; MOSKOWITZ, Chaya S et al.Clinical cancer research (Print). 2010, Vol 16, Num 18, pp 4647-4653, issn 1078-0432, 7 p.Article

Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimusRIELY, Gregory J; KRIS, Mark G; MILLER, Vincent A et al.Clinical cancer research. 2007, Vol 13, Num 17, pp 5150-5155, issn 1078-0432, 6 p.Article

A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancerRIZVI, Naiyer A; HUMPHREY, Jeffrey S; HURWITZ, Herbert et al.Clinical cancer research. 2004, Vol 10, Num 6, pp 1963-1970, issn 1078-0432, 8 p.Article

Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancerRIZVI, Naiyer A; MARSHALL, John L; KURIE, Jonathan M et al.Journal of clinical oncology. 2002, Vol 20, Num 16, pp 3522-3532, issn 0732-183XArticle

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane^®) given as a two-hour infusionPAIK, Paul K; JAMES, Leonard P; RIZVI, Naiyer A et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 5, pp 1331-1337, issn 0344-5704, 7 p.Article